Study Measures
death
SECONDARY
The GAP70+ trial collected 27 PRO-CTCAE symptom items with multiple attributes.The primary outcome of this study was whether a participant experienced unplanned hospitalization(s) within 3 months of starting a new treatment regimen. Any planned or scheduled admissions were excluded from the analysis. The secondary outcomes included all-cause mortality over 1 year of study enrollment and any grade 3 to 5 toxic effects within 3 months. Data on hospitalization and date of death were captured by practice staff. All clinician-reported grade 3 to 5 toxic effects were prospectively collected and reviewed using the NCI CTCAE version 4.